Cited by 203Inflammatory Bowel DiseaseGut microbiota and healthMicroscopic Colitis

The DOI matches its Crossref record; 40 of the 42 references it cites were found in a registry or an index, and 2 are not checked yet.

Faecal microbiota transplantation with anti-inflammatory diet (FMT-AID) followed by anti-inflammatory diet alone is effective in inducing and maintaining remission over 1 year in mild to moderate ulcerative colitis: a randomised controlled trial

Open access

Kedia, Saurabh, Virmani, Shubi, K Vuyyuru, Sudheer, Kumar, Peeyush, Kante, Bhaskar, Sahu, Pabitra, Kaushal, Kanav, Farooqui, Mariyam, Singh, Mukesh, Verma, Mahak, Bajaj, Aditya, Markandey, Manasvini, Sachdeva, Karan, Das, Prasenjit, Makharia, Govind K, Ahuja, Vineet·2022·Gut

DOI 10.1136/gutjnl-2022-327811

Open this paper in CoChat — free account Open PDF

Abstract

Objective Microbiome and dietary manipulation therapies are being explored for treating ulcerative colitis (UC). We aimed to examine the efficacy of multidonor faecal microbiota transplantation (FMT) and anti-inflammatory diet in inducing remission followed by long-term maintenance with anti-inflammatory diet in patients with mild-moderate UC. Design This open-labelled randomised controlled trial (RCT) randomised patients with mild-moderate (Simple Clinical Colitis Activity Index (SCCAI) 3–9) endoscopically active UC (Ulcerative Colitis Endoscopic Index of Severity (UCEIS)>1) on stable baseline medications in 1:1 ratio to FMT and anti-inflammatory diet (FMT-AID) versus optimised standard medical therapy (SMT). The FMT-AID arm received seven weekly colonoscopic infusions of freshly prepared FMT from multiple rural donors(weeks 0–6) with anti-inflammatory diet. Baseline medications were optimised in the SMT arm. Clinical responders (decline in SCCAI>3) at 8 weeks in both arms were followed until 48 weeks on baseline medications (with anti-inflammatory diet in the FMT-AID arm). Primary outcome measures were clinical response and deep remission (clinical—SCCAI <2; and endoscopic—UCEIS <1) at 8 weeks, and deep remission and steroid-free clinical remission at 48 weeks. Results Of the 113 patients screened, 73 were randomised, and 66 were included in (35—FMT-AID; 31—SMT) modified intention-to-treat analysis (age—35.7±11.1 years; male—60.1%; disease duration—48 (IQR 24–84) months; pancolitis—34.8%; SCCAI—6 (IQR 5–7); UCEIS—4 (IQR 3–5)). Baseline characteristics were comparable. FMT-AID was superior to SMT in inducing clinical response (23/35 (65.7%) vs 11/31 (35.5%), p=0.01, OR 3.5 (95% CI 1.3 to 9.6)), remission (21/35 (60%) vs 10/31 (32.3%), p=0.02, OR 3.2 (95% CI 1.1 to 8.7)) and deep remission (12/33 (36.4%) vs 2/23 (8.7%), p=0.03, OR 6.0 (95% CI 1.2 to 30.2)) at 8 weeks. Anti-inflammatory diet was superior to SMT in maintaining deep remission until 48 weeks (6/24 (25%) vs 0/27, p=0.007). Conclusion Multidonor FMT with anti-inflammatory diet effectively induced deep remission in mild-moderate UC which was sustained with anti-inflammatory diet over 1 year. Trial registration number ISRCTN15475780 .

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1136/gutjnl-2022-327811

Cites

40 of 42 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Ulcerative colitis
Ungaro, R. C., Mehandru, S., Allen, P. B., Peyrin‐Biroulet, L., & Colombel, J. (2016) · The Lancet · doi:10.1016/s0140-6736(16)32126-2 · Cited by 3,659
The role of short chain fatty acids in health and disease
Tan, J., McKenzie, C., Potamitis, M., Thorburn, A. N., Mackay, C. R., & Macia, L. (2014) · Advances in immunology · doi:10.1016/b978-0-12-800100-4.00003-9 · Cited by 2,425
Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice
Devkota, S., Wang, Y., Musch, M. W., Leone, V., Fehlner-Peach, H., Nadimpalli, A., Antonopoulos, D. A., Jabri, B., & Chang, E. B. (2012) · Nature · doi:10.1038/nature11225 · Cited by 1,904
Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial
Moayyedi, P., Surette, M. G., Kim, P. T., Libertucci, J., Wolfe, M., Onischi, C., Armstrong, D., Marshall, J. K., Kassam, Z., Reinisch, W., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.001 · Cited by 1,499
Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial
Paramsothy, S., Kamm, M. A., Kaakoush, N. O., Walsh, A. J., van den Bogaerde, J., Samuel, D., Leong, R. W. L., Connor, S., Ng, W., Paramsothy, R., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30182-4 · Cited by 1,276
Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 2: current management
Harbord, M., Eliakim, R., Bettenworth, D., Karmiris, K., Katsanos, K., Kopylov, U., Kucharzik, T., Molnár, T., Raine, T., Sebastian, S., et al. (2017) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjx009 · Cited by 1,180
Findings From a Randomized Controlled Trial of Fecal Transplantation for Patients With Ulcerative Colitis
Rossen, N. G., Fuentes, S., van der Spek, M. J., Tijssen, J. G., Hartman, J. H. A., Duflou, A., Löwenberg, M., van den Brink, G. R., Mathus-Vliegen, E. M. H., de Vos, W. M., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.03.045 · Cited by 921
Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis
Costello, S. P., Hughes, P. A., Waters, O., Bryant, R. V., Vincent, A. D., Blatchford, P. A., Katsikeros, R., Makanyanga, J. C., Campaniello, M. A., Mavrangelos, C., et al. (2019) · JAMA · doi:10.1001/jama.2018.20046 · Cited by 895
Dietary emulsifiers directly alter human microbiota composition and gene expression ex vivo potentiating intestinal inflammation
Chassaing, B., Van de Wiele, T., De Bodt, J., Marzorati, M., & Gewirtz, A. T. (2017) · Gut · doi:10.1136/gutjnl-2016-313099 · Cited by 590
Review article: insights into colonic protein fermentation, its modulation and potential health implications
Yao, C. K., Muir, J. G., & Gibson, P. R. (2016) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13456 · Cited by 441

Show all 42 references

Research works printed but not linked: 1

Singh, 2015, Dietary fiber content of Indian diets, Asian J Pharm Clin Res, 8, 58

Sorted by citations

Items 101–200 of 203

Structural Variations in Ulcerative Colitis–associated Escherichia coli Reduce Fructose Utilization and Aggravate Inflammation Under High-Fructose Diet
Wu, X., Li, Y., Li, P., Lu, G., Wu, J., Wang, Z., Wen, Q., Cui, B., Wang, J., & Zhang, F. (2025) · Gastroenterology · doi:10.1053/j.gastro.2025.03.039 · Cited by 12
Safety comparison of single-donor and pooled fecal microbiota transfer product preparation in ulcerative colitis: systematic review and meta-analysis
Laperrousaz, B., Levast, B., Fontaine, M., Nancey, S., Déchelotte, P., Dore, J. M., & Lehert, P. (2024) · BMC Gastroenterology · doi:10.1186/s12876-024-03487-2 · Cited by 10
The gut immune axis in ulcerative colitis: insights from microbiome research
Wasim, R. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-11124-8 · Cited by 10
It’s Time to Change Tack in IBD Treatment
Behr, M. A., Mehes, I., & Bernstein, C. N. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.06.036 · Cited by 10
The aqueous extract of Reynoutria japonica ameliorates damp-heat ulcerative colitis in mice by modulating gut microbiota and metabolism.
Jiang, L.-Y., Zhang, J., Zhu, B., Bao, X., Tian, J., Li, Y., Zhang, G., Wang, L., Zhang, W., Tang, Y., et al. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.119042 · Cited by 9
Comparative Effectiveness and Safety of Fecal Microbiota Transplantation in Ulcerative Colitis: An Updated Systematic Review and Meta-Analysis
Huang, B., An, H., Qiu, Y., Ye, T., Huang, Y., Zheng, M., Shi, D., Su, Y., & Wang, R. (2026) · Advances in Therapy · doi:10.1007/s12325-025-03431-0 · Cited by 9
Nanjing Consensus II on Washed Microbiota Transplantation: Statements From the CHINAGUT Conference
Zhang, F., Wong, H. S., Lu, G., Pi, Z., Zhang, T., Yu, H. H., Bu, N., Chen, X., Cui, B., Dafa, D., et al. (2026) · Microbiota Medicine Research · doi:10.1002/mmr3.70006 · Cited by 9
Metabolomic interplay between gut microbiome and plasma metabolome in cardiac surgery‐associated acute kidney injury
Bai, Y., Huang, W., Jiang, X., Wang, X., Li, Y., Wang, Y., Huang, S., Wu, K., Hu, L., & Chen, C. (2023) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.9504 · Cited by 9
A Systematic Review of the Role of Diet in Ulcerative Colitis
Abbas, N., Shakil, M., Rana, Z. A., Ali, S. B., Awan, A. A., & Gul, S. (2023) · Cureus · doi:10.7759/cureus.39350 · Cited by 9
Effectiveness of Fecal Microbiota Transplantation Treatment in Patients with Recurrent Clostridium Difficile Infection, Ulcerative Colitis, and Crohn's Disease: A Systematic Review
Jaramillo, A. P., Awosusi, B. L., Ayyub, J., Dabhi, K. N., Gohil, N. V., Tanveer, N., Hussein, S., Pingili, S., & Makkena, V. K. (2023) · Cureus · doi:10.7759/cureus.42120 · Cited by 9
Choosing Therapies in Ulcerative Colitis
Das, R., & Steinhart, A. H. (2023) · Journal of the Canadian Association of Gastroenterology · doi:10.1093/jcag/gwad025 · Cited by 9
Reduction of product composition variability using pooled microbiome ecosystem therapy and consequence in two infectious murine models
Reygner, J., Delannoy, J., Barba-Goudiaby, M.-T., Gasc, C., Levast, B., Gaschet, E., Ferraris, L., Paul, S., Kapel, N., Waligora‐Dupriet, A., et al. (2024) · Applied and Environmental Microbiology · doi:10.1128/aem.00016-24 · Cited by 11
l -Theanine Alleviates Ulcerative Colitis by Regulating Colon Immunity via the Gut Microbiota in an MHC-II-Dependent Manner
Xu, W., Liu, A.-X., Liu, K., Zhang, S., Gong, Z., & Xiao, W. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c04379 · Cited by 9
Digestive dynamics: Unveiling interplay between the gut microbiota and the liver in macronutrient metabolism and hepatic metabolic health
Kandalgaonkar, M. R., Kumar, V., & Vijay–Kumar, M. (2024) · Physiological Reports · doi:10.14814/phy2.16114 · Cited by 8
Baitouweng decoction modulates gut microbial production of indole-3-propionic acid and epithelial necroptosis to alleviate DSS-induced colitis in mice
Hu, J., Chen, H., Zhu, L., Tong, Y., Cheng, C., Yan, G., & Shen, H. (2025) · Chinese Medicine · doi:10.1186/s13020-025-01143-9 · Cited by 8
Faecal Transplantation for Ulcerative Colitis From Diet Conditioned Donors Followed by Dietary Intervention Results in Favourable Gut Microbial Profile Compared to Faecal Transplantation Alone
Leibovitzh, H., Shabat, C. S., Hirsch, A., Zittan, E., Mentella, M. C., Petito, V., Cohen, N. A., Ron, Y., Isakov, N. F., Pfeffer, J., et al. (2024) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjae062 · Cited by 8
Diet and Microbiota Modulation for Chronic Pouchitis: Evidence, Challenges, and Opportunities
Puca, P., GAUDIO, A. D., Becherucci, G., Sacchetti, F., Sofo, L., Lopetuso, L. R., Papa, A., Cammarota, G., & Scaldaferri, F. (2024) · Nutrients · doi:10.3390/nu16244337 · Cited by 7
FMT reduces systemic inflammatory response in severe acute pancreatitis by increasing the abundance of intestinal Bifidobacteria and fecal bacteria
Mao, Y., Yandong, H., Zhang, W., Liang, H., Liu, F., Luo, Q., Xu, C., Qin, Y., Liu, J., Tang, S., et al. (2024) · Biomolecules and Biomedicine · doi:10.17305/bb.2024.11445 · Cited by 7
Inflammatory Signatures and Biological Markers in Platelet-Rich Plasma Therapy for Hair Regrowth: A Comprehensive Narrative Analysis
Vrapcea, A., Pisoschi, C. G., Ciupeanu-Călugăru, E. D., Trasca, E.-T., Tutunaru, C. V., Radulescu, P.-M., & Rădulescu, D. (2025) · Diagnostics · doi:10.3390/diagnostics15091123 · Cited by 7
Gut microbiota: origin or panacea for all ills? Immune and metabolic diseases, nutrition, and microbiota-based interventions
Colica, C., & Vecchio, I. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.108213 · Cited by 8
Fecal microbiota transplantation in inflammatory bowel disease: a systematic review and meta-analysis of randomized controlled trials (2020–2025)
Ikram, S., Ullah, M., Lee, J., Hasan, N., Yoo, J., Khan, R., & Naeem, M. (2026) · Inflammopharmacology · doi:10.1007/s10787-026-02174-w · Cited by 7
DAMP-ing IBD: Extinguish the Fire and Prevent Smoldering
Sandys, O., Stokkers, P. C. F., & Velde, A. A. T. (2024) · Digestive Diseases and Sciences · doi:10.1007/s10620-024-08523-5 · Cited by 9
Role of microbiota in pain: From bench to bedside
Ren, H., Cao, B., Xu, Q., Zhao, R., Li, H., & Wei, B. (2025) · iMetaOmics. · doi:10.1002/imo2.58 · Cited by 7
Virome drift in ulcerative colitis patients: faecal microbiota transplantation results in minimal phage engraftment dominated by microviruses
Jansen, D., Deleu, S., Caenepeel, C., Marcelis, T., Simsek, C., Falony, G., Machiels, K., Sabino, J., Raes, J., Vermeire, S., et al. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2499575 · Cited by 6
Fecal microbiota transfer to treat ulcerative colitis: Medical and legal challenges
Steube, A., Stallhofer, J., & Stallmach, A. (2023) · Frontiers in Gastroenterology · doi:10.3389/fgstr.2023.1161610 · Cited by 6
Patient preferences for active ulcerative colitis treatments and fecal microbiota transplantation
Marshall, D. A., MacDonald, K. V., Kao, D. H., Bernstein, C. N., Kaplan, G. G., Jijon, H. B., Hazlewood, G. S., Panaccione, R., Nasser, Y., Raman, M., et al. (2024) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223241239168 · Cited by 6
Efficacy and safety of fecal microbiota transplantation for treatment of ulcerative colitis: A post-consensus systematic review and meta-analysis
Zhang, J., Zhang, N., Dong, X.-T., Wang, X., Ma, H., Liu, Y., & Li, M.-R. (2024) · World Journal of Clinical Cases · doi:10.12998/wjcc.v12.i21.4691 · Cited by 6
Use of autoprobiotics in the complex therapy of axial spondyloarthritis
Artemev, I. A., Ермоленко, Е. И., Котылева, М. П., Gladysheva, N. P., Tsapieva, A., Gaydukova, I. Z., Леонидович, Ч. А., Suvorov, A. N., & Maslyansky, A. L. (2023) · Russian Journal for Personalized Medicine · doi:10.18705/2782-38062023-3-1-80-97 · Cited by 6
Manipulation of the intestinal microbiome-a slow journey to primetime
Kriger-Sharabi, O., Malnick, S. D. H., & Fisher, D. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i21.4975 · Cited by 6
Effectiveness and safety of non-pharmacological therapies for the treatment of inflammatory bowel disease: a network meta-analysis
Jia, J., Wu, Y., Liu, S., Chen, W., Li, R., Bai, Y., & Hu, L. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1593483 · Cited by 5
Interactional Effects of Food Macronutrients with Gut Microbiome: Implications for Host Health and Risk
Tan, Z., Yang, C., Zhao, Y., Yang, X., & Li, T. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.5c04034 · Cited by 6
Fecal Microbiota Transplantation for Inflammatory Bowel Disease: Where We Stand and What Is Next
Ishikawa, D., Zhang, X., Nomura, K., & Nagahara, A. (2025) · Inflammatory Intestinal Diseases · doi:10.1159/000549227 · Cited by 5
From gut dysbiosis to eubiosis: understanding microbiome recovery as an ecological process
Kennedy, M. S., & Chang, E. B. (2026) · Gut Microbes · doi:10.1080/19490976.2026.2649448 · Cited by 5
A predictive machine-learning model for clinical decision-making in washed microbiota transplantation on ulcerative colitis
Zhang, S., Lu, G., Wang, W., Li, Q., Wang, R., Zhang, Z., Wu, X., Liang, C., Liu, Y., Li, P., et al. (2024) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2024.08.021 · Cited by 5
Faecal Microbiota Transplantation as an Adjuvant Treatment for Extraintestinal Disorders: Translating Insights from Human Medicine to Veterinary Practice
Nishigaki, A., Marchesi, J. R., & Previdelli, R. L. (2025) · Veterinary Sciences · doi:10.3390/vetsci12060541 · Cited by 5
Nourishing the gut: the impact of diet on host–gut microbiota interaction
Masi, D., Roy, T. L., Adriouch, S., & Clément, K. (2024) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000001009 · Cited by 6
Novel opportunity of treatment for psycho-cardiologic disease by gut microbiome
Lai, Y., Fang, C., Jiang, Y., Yang, C., Zhou, Q., Cai, Y., Yan, W., & Fan, X. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1604962 · Cited by 4
Translocator protein facilitates neutrophil-mediated mucosal inflammation in inflammatory bowel diseases
He, Q., Wu, X., Jiang, D., Lin, R., Xie, F. X., Guan, Y., & Fei, A. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i27.109239 · Cited by 4
Examining the role of fecal microbiota transplantation for inducing remission in resistant ulcerative proctitis and distal ulcerative colitis (ulcerative proctitis-fecal microbiota transplantation)
Raja, S. S., Costello, S. P., Rayner, C. K., Day, A. S., Portmann, L., Uylaki, W., Wheeler, R., Saxon, S., Tucker, E. C., Fon, J., et al. (2025) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaf169 · Cited by 4
Diet in Ulcerative Colitis: A Narrative Review of Its Role in Pathogenesis and Treatment
Jamal, F., Odeh, N. B., Alatout, M. H., Khan, M. A., Pasha, S. B., & Malik, T. A. (2025) · Digestive Diseases and Sciences · doi:10.1007/s10620-025-09387-z · Cited by 4
Effectiveness and Safety of Fecal Microbiota Transplantation for Ulcerative Colitis Treatment: A Systematic Review and Meta-Analysis
Doukas, P. G., Doukas, S. G., & Broder, A. (2025) · Digestive Diseases · doi:10.1159/000548568 · Cited by 4
Cutting edge developments and novel targets in IBD: Microbiome in IBD
Deleu, S., & Sabino, J. P. G. (2025) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2025.102060 · Cited by 4
Nutritional composition of diets for inducing and maintaining remission in inflammatory bowel diseases: from bedside to plate
Godny, L., Pfeffer‐Gik, T., Elial-Fatal, S., Shakhman, S. R., & Dotan, I. (2025) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2025.102587 · Cited by 4
Gut microbiota in pathogenesis and therapeutic potentials in rheumatoid arthritis
Cui, H., Liu, Q., Leung, P. S. C., Chow, M. W., Liu, S., & Liu, B. (2026) · Current Opinion in Immunology · doi:10.1016/j.coi.2026.102760 · Cited by 4
The role of the fecal microbiota in inflammatory bowel disease
Khalaf, R., Sciberras, M., & Ellul, P. (2024) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002818 · Cited by 5
The biodiversity dose-response curve translates theory and practice from ecological restoration into research and clinical priorities for fecal microbiota transplantation
Orr, M. R. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1059148 · Cited by 4
FMT for hepatic encephalopathy? The THEMATIC trial aims to make it a ‘no brainer’
Shawcross, D. L., & Patel, V. (2025) · Journal of Hepatology · doi:10.1016/j.jhep.2025.03.009 · Cited by 4
Efficacy and safety of Gegen Qinlian decoction combined with mesalazine for the treatment of UC: A meta-analysis and systematic review
Chen, Y., Li, R., Yuan, Y., He, H., Yang, W. T., Yuan, C., Xiao, J., Qin, Y., Lian, M., & Yang, Z. (2025) · Medicine · doi:10.1097/md.0000000000042266 · Cited by 3
The Impact of Diet on the Fecal Microbiota Transplantation Success in Patients with Gastrointestinal Diseases—A Literature Review
Komorniak, N., Gaweł, K., Deskur, A., Pawlus, J., & Stachowska, E. (2025) · Nutrients · doi:10.3390/nu17203314 · Cited by 3
Gut microbiota and nutritional interventions in alcohol-associated liver disease: Mechanisms and therapeutic advances
Mittal, A., & Sharma, S. (2025) · Nutrition Research · doi:10.1016/j.nutres.2025.11.004 · Cited by 3
Gut microbiota and macrophage crosstalk: implications for colitis-associated colorectal cancer
Lyu, W., Zhang, Z., Liu, L., Sun, Y., Wang, B., Zhou, C., Liu, Z., & Feng, B. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1778244 · Cited by 3
One therapy, many targets: redefining ulcerative colitis treatment through fecal microbiota transplantation
Rynikova, M., Bojcukova, V., & Demečková, V. (2026) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848261437918 · Cited by 3
Intestinal Barrier: Mechanisms of Disruption and Strategies for Restoration in Ulcerative Colitis
Wang, M.-N., Liu, C.-G., Pan, J., Pang, X.-G., & Liu, H. (2026) · Gastrointestinal Disorders · doi:10.3390/gidisord8020024 · Cited by 3
Recent advances in our understanding of the gut microbiome: an analysis from the Gut Microbiota for Health Expert Panel of the British Society of Gastroenterology
Alexander, J. B., Mullish, B. H., Thomas, L., Weersma, R. K., Sokol, H., Roberts, L. A., Edwards, L. A., Emmanuel, A. V., Gerasimidis, K., Hall, L. J., et al. (2026) · Gut · doi:10.1136/gutjnl-2026-338252 · Cited by 5
Efficacy of Whole-Food Based Anti-inflammatory Dietary Interventions in the Management of Ulcerative Colitis: A Systematic Review and Meta-Analysis
Rehmat, M., Haq, U. U., Saddique, M. N., Mehmood, L., Fatima, N., Younas, M., Iqbal, M. U., Rahman, M. U., Khan, M. A., & Haq, Z. U. (2025) · Digestive Diseases and Sciences · doi:10.1007/s10620-025-09332-0 · Cited by 3
Probiotics and diet quality: modulation of gut microbiota on intestinal infection and inflammation
Bostan, Z. Z., Aygun, B. B., & Cergel, E. (2025) · Precision Nutrition · doi:10.1097/pn9.0000000000000128 · Cited by 3
Gut microbes of the cecum versus the colon drive more severe lethality and multi-organ damage
Xu, K., Tan, J., Lin, D., Jiang, H., Chu, Y., Zhou, L., Zhang, J., & Lu, Y. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114029 · Cited by 3
Glehnia littoralis polysaccharides alleviate lung and intestinal mucosal barrier damage in rats with ulcerative colitis via aryl hydrocarbon receptor activation.
Geng, X., Liu, J., Feng, H., Xu, J., Gu, J., Ding, X., Zhou, G., Zhang, T.-S., Liu, Y.-S., Wang, M., et al. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.147318 · Cited by 3
The Role of Gut Microbiota and Mucin Barrier in the Pathogenesis of Colorectal Cancer
Chen, Y., Xu, Y., Li, X., Wu, S., 龙红, Fu, G., & Xiao, S. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb48010016 · Cited by 2
Food as Medicine: Enhancing Crop Breeding and Food Processing to Shift the Gut Microbiome for Prevention and Treatment of Chronic Diseases
Mannon, P., Benson, A. K., Schnable, J. C., Ding, W. R., Juritsch, A. F., & Rose, D. J. (2025) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.101298 · Cited by 2
Study Design Complexity and Participant Completion in Dietary Trials for Inflammatory Bowel Disease: A Systematic Review and Metaresearch Study
Gregersen, L., Moos, C. M., Hikmat, Z., Rasmussen, N. F., Petersen, S. R., Heitmann, B. L., Halldorsson, T. I., Andersen, V. C., & Christensen, R. (2026) · Advances in Nutrition · doi:10.1016/j.advnut.2026.100614 · Cited by 2
Additive effects of fecal microbiota transplantation and infliximab on gut microbiome and metabolome in refractory inflammatory bowel disease patients
Wang, X., Wu, W., Yang, B., Liu, Y., Xu, Y., Wang, L., Lv, X., Gao, J., Lu, M., Yu, A., et al. (2026) · mSystems · doi:10.1128/msystems.00774-25 · Cited by 2
Antifungal therapy improves microbiome dynamics in inflammatory bowel disease
Pan, X., Conroy, A., Ngima, T. S., Mesko, M., Morzhanaeva, O., Li, A., Marino, J., Westblade, L. F., Grier, A., Bächer, P., et al. (2026) · Nature Medicine · doi:10.1038/s41591-026-04616-y · Cited by 2
Deficiency of miRNA-149-3p shaped gut microbiota and enhanced dextran sulfate sodium-induced colitis
Kankuri, E. M. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.01.011 · Cited by 2
Management of Ulcerative Colitis: A Review of Indian Literature
Rajendran, S., Kini, R., Muthukumaran, K., Shubha, I., Annasamy, C., & Murali, R. (2023) · Gastroenterology Hepatology and Endoscopy Practice · doi:10.4103/ghep.ghep_17_23 · Cited by 1
Recent Advancement of Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis- A Review
Lin, Y., Wang, P., Hu, X., Wang, Q., Shi, Q., Zhou, Y., Liu, R., & Cai, X. (2025) · Current Medicinal Chemistry · doi:10.2174/0109298673404225250730100935 · Cited by 1
Role of diet in shaping the gut microbiome
Siddiqui, B., Tiwari, S., Fatima, S., & Abdin, M. Z. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40483-2.00027-3
Fecal microbiota transplantation in ulcerative colitis: mucosal immune mechanisms and precision microbiota therapy
Lu, E., Zhang, M., Zhao, Y., Meng, H., & Xu, Z. Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1888117 · Cited by 1
Role of microbiota in the outcome of immune checkpoint inhibition therapy of cancer
Rijkers, G. T., Langcauon, Y., van Leersum, P., Popović, L., & van Overveld, F. J. (2025) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2025.1002348 · Cited by 1
Sarcandra glabra alleviates intestinal injury via modulating gut microbiota and suppressing the IL-6/SOCS3 signaling pathway
Huang, S., Chi, X., 宋思婷, Gao, X., Yu, D., Huang, W., Wang, J., Chen, L., & Li, H. (2026) · npj Science of Food · doi:10.1038/s41538-026-00968-4 · Cited by 1
Therapieupdate 2022: Colitis ulcerosa
Hoffmann, J., & Edelmann, J. (2023) · Die Gastroenterologie · doi:10.1007/s11377-022-00661-4 · Cited by 1
Centipeda minima (L.) A. Braun & Asch. and its representative active compound alleviate DSS-induced ulcerative colitis via inhibition of NLRP3 inflammasome activation and regulation of gut microbiota
Tan, J., Wang, S., Gan, S., Chen, H., Zhong, K., Kwan, H. Y., Fan, X., Xiao, B., Liang, Q., Liu, Z., et al. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106207 · Cited by 1
Macrophage-Stimulating 1 Polymorphism rs3197999 in Pediatric Patients with Inflammatory Bowel Disease
Brylak, J., Nowak, J. K., Dybska, E., Glapa-Nowak, A., Kierkuś, J., Osiecki, M., Banaszkiewicz, A., Radzikowski, A., Szaflarska‐Popławska, A., Kwiecień, J., et al. (2024) · Medicina · doi:10.3390/medicina60081243 · Cited by 1
Fecal microbiota transplantation in alcoholic hepatitis: new treatment paradigm or a shot in the dark?
Anirvan, P., Panigrahi, M. K., & Singh, S. P. (2023) · Hepatology International · doi:10.1007/s12072-023-10525-w · Cited by 1
Therapieupdate 2022: Colitis ulcerosa
Hoffmann, J., & Edelmann, J. (2023) · Wiener klinisches Magazin · doi:10.1007/s00740-023-00484-1
Fecal microbiota transplantation: modulation of metabolic and inflammatory intestinal diseases
Tavares, P. A., Minniti, G. A. D. S., Sampaio, M. L. S., Laurindo, L. F., Rossato, E. L. M., Beraldo, F., Minnti, G., Pilon, J. P. G., dos Santos, J. P., & Barbalho, S. M. (2023) · Peer Review · doi:10.53660/542.prw2008
Sinnhaftigkeit von Diäten bei Erkrankungen des Verdauungstrakts
Vogelsang, H., & Schreiner, P. (2023) · Journal für Gastroenterologische und Hepatologische Erkrankungen · doi:10.1007/s41971-023-00157-0
Ulcerative Colitis and Dietary Patterns
潘, 慧. (2024) · Advances in Clinical Medicine · doi:10.12677/acm.2024.141036
Mucosal disease activity may predict response to fecal microbiota transplantation in patients with ulcerative colitis
Kellermayer, R., Nagy‐Szakal, D., Ihekweazu, F. D., Luna, R. A., & Versalovic, J. A. (2025) · Pediatric Research · doi:10.1038/s41390-025-04120-y
‘Mining’ the Gut: The Microbiome ‘Lassonde curve’
NARANG, H., & Ahuja, V. (2025) · The National Medical Journal of India · doi:10.25259/nmji_1737_2025
Self-citation
Gut Microbiota and Inflammatory Profiles in Endometriosis: A Retrospective Study Based on 16S rRNA Sequencing
Wu, H., Wang, W., Zhu, W., & Ma, S. (2025) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/ceog44257
Fecal microbiota transplantation in compassionate indications: French experience from 2019 to 2022
Vullierme, P. N., Galperine, T. K., Benech, N., Alric, L., Mosca, A., Joly, A., Kapel, N., Scanzi, J., Landman, C., Sokol, H., et al. (2026) · Infectious Diseases Now · doi:10.1016/j.idnow.2026.105247
AUTO-brewery syndrome and the human microbiome: Insights into endogenous ethanol production and human diseases
Kamaljeet, Vijukumar, A., Shahi, A., Kumar, A., & Bhatia, R. (2026) · Food Science and Biotechnology · doi:10.1007/s10068-026-02103-1
Effects of diet, dietary inflammatory index, modified antiinflammatory dietary intervention via diet management platform on short-term prognosis in patients with ulcerative colitis: A prospective study
Zhang, Y., Ruan, G., Zeng, K., Li, R., & Yang, H. (2026) · Nutrition · doi:10.1016/j.nut.2026.113157
Diet-conditioned microbiota enhances fecal microbiota transplantation efficacy in alcoholic liver disease through caproic acid-PPARα signalingPreprint
Choudhary, N., Mittal, A., Kumar, S., Yadav, K., Kumari, A., Maheshwari, D., Rath, P. P., Maras, J. S., Mohmmed, A., Kumar, A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.03.25.714243
The Role of Microbiota and Fecal Transplantation in Inflammatory Bowel Disease
Villaseca, I. L., de Arce, E. P., Faggiani, I., D’Amico, F., Zilli, A., Furfaro, F., Massironi, S., Cicerone, C., Solitano, V., Parigi, T. L., et al. (2026) · Pathogens · doi:10.3390/pathogens15040451
Diet-conditioned microbiota enhances fecal microbiota transplantation efficacy in alcoholic liver disease through caproic acid-PPARα signalingPreprint
Choudhary, N., Mittal, A., Kumar, S., Yadav, K., Kumari, A., Maheshwari, D., Maras, J. S., Kumar, A., Sarin, S. K., & Sharma, S. (2026) · eLife · doi:10.7554/elife.111301
Diet-conditioned microbiota enhances fecal microbiota transplantation efficacy in alcoholic liver disease through caproic acid-PPARα signalingPreprint
Choudhary, N., Mittal, A., Kumar, S., Yadav, K., Kumari, A., Maheshwari, D., Maras, J. S., Kumar, A., Sarin, S. K., & Sharma, S. (2026) · eLife · doi:10.7554/elife.111301.1
Remission rates and safety of fecal microbiota transplantation in inflammatory bowel disease in adult patients: A systematic review
Alharoun, O., Abdo, N., Dimassi, S., Kanbar, T., Ossaily, K., Tahhan, S., Saba, J. B., Kazzi, M. A., Sinno, A., & Khoury, C. A. (2026) · Sage Open Chronic Disease · doi:10.1177/27558428261449952
Tetramethylpyrazine ameliorates ulcerative colitis via B. pseudolongum -driven taurine metabolism and M2macrophage polarizationPreprint
Huang, Z., Zhu, X., Chen, Y., Wan, H., Yao, D., Peng, M., Deng, X., Yin, J., Zhang, X., He, Y. U. E. J. I., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10454410/v1
Optimized fecal microbiota transplantation using membrane-filtered bacterial concentrates as adjunctive therapy for mild-to-moderate ulcerative colitis: a retrospective cohort study
Tang, J., Chen, L., Wang, Q., He, X., Hang, D., Chen, G., & Feng, L. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1805799
Diagnostic and therapeutic potentials targeting the interplay of host barriers and microbiota in human gastrointestinal diseases
Bai, X., Ihara, E., & Akiho, H. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40306-4.00016-8
Fecal Microbiota Transplantation (FMT) in the Management of Ulcerative Colitis: A Comprehensive Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs)
Ahad, A., Kumar, S., Kolomar, H., Williams, J., Abdallah, A. I., Sadeghzadegan, A., Yateem, D., Kharel, P., Chowdhury, D., Alnajar, F., et al. (2026) · Cureus · doi:10.7759/cureus.111804
MIF Deficiency Modulates Gut Microbiota Composition and Promotes Colitis-Associated Colorectal Cancer in a Murine Model
Navia, S. E. H., Illescas, O., Silva-Magaña, M. A., Juárez‐Avelar, I., Terrazas-Rodriguez, M., Vaca‐Paniagua, F., Velásquez, C. E. D., Vega, L., Terrazas, L. I., & Rodríguez‐Sosa, M. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48070712
Gegen Qinlian Decoction, a classic traditional Chinese medicine formula: a potential therapeutic strategy for ulcerative colitis and colorectal cancer
Hou, Y., Wang, H., Li, J., Li, C., Sun, Y., Wang, Y., Zou, D., & Zhou, L. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1868875
The Microbiome in the Development and Treatment of Inflammatory Bowel Disease
Zhetkenev, S., Konovalov, R., Akhmetkaliyev, A., & Sonnenberg-Riethmacher, E. (2026) · Biomedicines · doi:10.3390/biomedicines14081754
Integrated multi-omics, network pharmacology, and experimental validation reveal the protective mechanisms of curcumol against DSS-induced ulcerative colitis
Shu, F., Chen, K.-Q., Song, Y.-J., Li, J.-H., Shen, M., Guo, Z.-W., Lai, H.-Y., Xu, Y., Lei, N., Zheng, F.-J., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1852138
Ülseratif Kolit’in Tibbi Beslenme Tedavisinde Güncel Diyet Modelleri
Abacı, M., & Palamutoğlu, M. İ. (2026) · Türkiye Sağlık Bilimleri ve Araştırmaları Dergisi · doi:10.51536/tusbad.1780241
A functional immune-based platform for donor-recipient matching in faecal microbiota transplantation for inflammatory bowel disease
Amoroso, C., Strati, F., Maragno, P., Caridi, B., Noviello, D., Gilodi, M., Muià, M., Frazzini, S., Perillo, F., Vecchi, M. L., et al. (2026) · EBioMedicine · doi:10.1016/j.ebiom.2026.106475
Microbiome-targeted dietary therapy in health and disease: Challenges, opportunities, and pathways forward
Day, A. S., Armet, A. M., Kamath, S., Joyce, P., Bryant, R. V., & Armstrong, H. (2026) · Gut Microbes Reports · doi:10.1080/29933935.2026.2744027

Authors: Kedia, S., Virmani, S., K Vuyyuru, S., Kumar, P., Kante, B., Sahu, P., Kaushal, K., Farooqui, M., Singh, M., Verma, M., Bajaj, A., Markandey, M., Sachdeva, K., Das, P., Makharia, G. K., & Ahuja, V.
Affiliations: All India Institute of Medical Sciences (IN)
Corresponding author: Ahuja, Vineet
ORCID: Kedia, Saurabh
Virmani, Shubi
K Vuyyuru, Sudheer
Kumar, Peeyush
Kante, Bhaskar
Sahu, Pabitra
Kaushal, Kanav
Farooqui, Mariyam
Singh, Mukesh
Verma, Mahak
Bajaj, Aditya
Markandey, Manasvini
Sachdeva, Karan
Das, Prasenjit
Makharia, Govind K
Ahuja, Vineet
Venue: Gut
Publisher: BMJ
Published: 2022-08-16
Volume: 71
Issue: 12
Pages: 2401-2413
ISSN: 0017-5749 (ISSN-L)
1468-3288
DOI: 10.1136/gutjnl-2022-327811
OpenAlex: W4291993695
Cited by: 201
References: 42
Citations by year: 2026: 36 · 2025: 65 · 2024: 51 · 2023: 43 · 2022: 6
FWCI: 24.98
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Gut (publishedVersion)
PubMed (publishedVersion)
Funders: Indian Council of Medical Research (55/4/11/CARE-ID/2018-NCD-II)
Topics: Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
Keywords: fecal microbiota transplantation, anti-inflammatory diet, ulcerative colitis, deep remission, remission maintenance, steroid-free remission, dietary therapy, gut microbiota, endoscopic remission, clinical remission, inflammatory bowel disease treatment, quality of life
MeSH terms: Fecal Microbiota Transplantation, Anti-Inflammatory Agents, Colitis, Ulcerative, Diet, Humans, Male, Remission Induction, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Faecal microbiota transplantation with anti-inflammatory diet (FMT-AID) followed by anti-inflammatory diet alone is effective in inducing and maintaining remission over 1 year in mild to moderate ulcerative colitis: a randomised controlled trial

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks